Here are four key trends:
1. The market is estimated to grow from $143.7 million in 2014 to just under $2.1 billion by 2021.
2. It is expected to grow at a compound annual growth rate of 42.1 percent.
3. The market is driven primarily by new product approvals.
4. There are four bioabsorbable scaffold devices that have received the CE Mark in the five European countries.
More articles on devices:
Oxford Performance Materials’ SpineFab VBR gets FDA clearance — 5 key notes
FH Orthopedics becoming key player in European spine solutions market: 7 notes
Grand jury indicts troubled Texas spine surgeon — 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
